1. Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial. Issue 4 (April 2017) Authors: Zakrzewska, Joanna M; Palmer, Joanne; Morisset, Valerie; Giblin, Gerard MP; Obermann, Mark; Ettlin, Dominik A; Cruccu, Giorgio; Bendtsen, Lars; Estacion, Mark; Derjean, Dominique; Waxman, Stephen G; Layton, Gary; Gunn, Kevin; Tate, Simon Journal: Lancet neurology Issue: Volume 16:Issue 4(2017:Apr.) Page Start: 291 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗